Literature DB >> 20306830

Lobular breast carcinoma and its variants.

Emad A Rakha1, Ian O Ellis.   

Abstract

Lobular carcinoma is a special type of breast cancer that shows distinct clinical presentation, morphologic and molecular features, and clinical behavior, and its incidence is rising in recent years. Infiltrating lobular carcinoma (ILC) and its precursor lesions may result in diagnostic difficulties, particularly in the screening settings and their management may be problematic. Variants of lobular carcinoma, such as the pleomorphic variant, although not common, exist and some show differences in behavior warranting their recognition in view of requirements for different management strategies. Here we present a review of lobular carcinomas with particular attention to lobular in situ lesions, epidemiology, subtypes, diagnosis, molecular pathology, and grading of ILC in addition to the clinical behavior, response to therapy, and outcome of patients with ILC.

Entities:  

Mesh:

Year:  2010        PMID: 20306830     DOI: 10.1053/j.semdp.2009.12.009

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  42 in total

1.  Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.

Authors:  Otto Metzger-Filho; Arlindo R Ferreira; Rinath Jeselsohn; William T Barry; Deborah A Dillon; Jane E Brock; Ines Vaz-Luis; Melissa E Hughes; Eric P Winer; Nancy U Lin
Journal:  Oncologist       Date:  2018-12-05

2.  Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?

Authors:  Niamh Conlon; Dara S Ross; Jane Howard; Jeffrey P Catalano; Maura N Dickler; Lee K Tan
Journal:  Breast J       Date:  2015-08-14       Impact factor: 2.431

3.  Efficacy of Single-Agent Chemotherapy for Patients with Advanced Invasive Lobular Carcinoma: A Pooled Analysis from Three Clinical Trials.

Authors:  José Pérez-Garcia; Javier Cortés; Otto Metzger Filho
Journal:  Oncologist       Date:  2018-12-21

4.  ASO Author Reflections: Early-Stage Lobular Breast Cancer: Axillary Treatment in the Z0011 Era.

Authors:  Anita Mamtani; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2019-08-29       Impact factor: 5.344

Review 5.  Paradigm Shifts in Breast Care Delivery: Impact of Imaging in a Multidisciplinary Environment.

Authors:  Savitri Krishnamurthy; Therese Bevers; Henry M Kuerer; Benjamin Smith; Wei Tse Yang
Journal:  AJR Am J Roentgenol       Date:  2016-12-08       Impact factor: 3.959

6.  Breast Cancers of Special Histologic Subtypes Are Biologically Diverse.

Authors:  Audree B Tadros; Hannah Y Wen; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2018-08-09       Impact factor: 5.344

7.  Unifocal Invasive Lobular Carcinoma: Tumor Size Concordance Between Preoperative Ultrasound Imaging and Postoperative Pathology.

Authors:  Gopal R Vijayaraghavan; Srinivasan Vedantham; Gabriela Santos-Nunez; Rebecca Hultman
Journal:  Clin Breast Cancer       Date:  2018-07-27       Impact factor: 3.225

Review 8.  Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications.

Authors:  Romualdo Barroso-Sousa; Otto Metzger-Filho
Journal:  Ther Adv Med Oncol       Date:  2016-04-25       Impact factor: 8.168

9.  Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17.

Authors:  Natalya Khilko; Jianmin Wang; Bing Wei; David G Hicks; Ping Tang
Journal:  Breast Cancer (Auckl)       Date:  2010-10-21

10.  Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.

Authors:  Otto Metzger Filho; Anita Giobbie-Hurder; Elizabeth Mallon; Barry Gusterson; Giuseppe Viale; Eric P Winer; Beat Thürlimann; Richard D Gelber; Marco Colleoni; Bent Ejlertsen; Marc Debled; Karen N Price; Meredith M Regan; Alan S Coates; Aron Goldhirsch
Journal:  J Clin Oncol       Date:  2015-07-27       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.